These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22334268)

  • 21. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.
    Garaud S; Le Dantec C; Jousse-Joulin S; Hanrotel-Saliou C; Saraux A; Mageed RA; Youinou P; Renaudineau Y
    J Immunol; 2009 May; 182(9):5623-32. PubMed ID: 19380809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD38 protein deficiency induces autoimmune characteristics and its activation enhances IL-10 production by regulatory B cells.
    Domínguez-Pantoja M; López-Herrera G; Romero-Ramírez H; Santos-Argumedo L; Chávez-Rueda AK; Hernández-Cueto Á; Flores-Muñoz M; Rodríguez-Alba JC
    Scand J Immunol; 2018 Jun; 87(6):e12664. PubMed ID: 29603313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1997 Sep; 10(9):859-63. PubMed ID: 9310947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell surface antigen CD5 is a marker for activated human B cells.
    Werner-Favre C; Vischer TL; Wohlwend D; Zubler RH
    Eur J Immunol; 1989 Jul; 19(7):1209-13. PubMed ID: 2474446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD5 positive B lymphocytes: a link between autoimmunity and B-cell oncogenesis.
    Bataille R; Klein B
    Anticancer Res; 1988; 8(4):707-10. PubMed ID: 2460021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presentation of antigen by B cell subsets. II. The role of CD5 B cells in the presentation of antigen to antigen-specific T cells.
    Zimecki M; Kapp JA
    Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):349-53. PubMed ID: 8572891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A CD5+ B cell hybridoma derived factor(s), which induces maturation of CD5+, idiotype-specific B-cell populations.
    Gibson M; Hardin JA; Sherr DH
    J Mol Cell Immunol; 1990; 4(5):241-51; discussion 251-3. PubMed ID: 1698380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-10 production by B cells expressing CD5 with the alternative exon 1B.
    Garaud S; Le Dantec C; de Mendoza AR; Mageed RA; Youinou P; Renaudineau Y
    Ann N Y Acad Sci; 2009 Sep; 1173():280-5. PubMed ID: 19758163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Origins and functions of B-1 cells with notes on the role of CD5.
    Berland R; Wortis HH
    Annu Rev Immunol; 2002; 20():253-300. PubMed ID: 11861604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and immunophenotypic characterization of murine B10 B cells.
    Hong C; Gao XM
    Methods Mol Biol; 2014; 1190():35-44. PubMed ID: 25015271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-regulatory cells in autoimmunity and immune mediated inflammation.
    Vadasz Z; Haj T; Kessel A; Toubi E
    FEBS Lett; 2013 Jun; 587(13):2074-8. PubMed ID: 23707422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory B10 cell development and function.
    Lykken JM; Candando KM; Tedder TF
    Int Immunol; 2015 Oct; 27(10):471-7. PubMed ID: 26254185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hiding in plain sight: time to unlock autoimmune clues in human CD5+ B cells by using nextgen technology.
    Ahmed R; Omidian Z; Donner T; Hamad ARA
    Discov Med; 2018 Sep; 26(142):79-83. PubMed ID: 30399325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The multiple faces of CD5.
    Burgueño-Bucio E; Mier-Aguilar CA; Soldevila G
    J Leukoc Biol; 2019 May; 105(5):891-904. PubMed ID: 30676652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition.
    Kasaian MT; Casali P
    Autoimmunity; 1993; 15(4):315-29. PubMed ID: 7511005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are bacterial endotoxins involved in autoimmunity by CD5+ (Ly-1+) B cells?
    van Rooijen N
    Immunol Today; 1989 Oct; 10(10):334-6. PubMed ID: 2478143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [At the crossroads between B lymphoproliferative syndromes to autoimmune diseases are CD5-positive B-lymphocytes: a new hypothesis].
    Youinou P
    Bull Acad Natl Med; 1999; 183(1):159-69; discussion 170. PubMed ID: 10371774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [CD5 positive b-lymphocytes in autoimmunity: possible role in Graves' disease].
    Afeltra A; Russo S; Peri C; Paggi A
    Riv Eur Sci Med Farmacol; 1995; 17(5):167-74. PubMed ID: 8766784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent progress in the understanding of B-cell functions in autoimmunity.
    Porakishvili N; Mageed R; Jamin C; Pers JO; Kulikova N; Renaudineau Y; Lydyard PM; Youinou P
    Scand J Immunol; 2001; 54(1-2):30-8. PubMed ID: 11439145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.